U.S. Markets open in 2 hrs 53 mins


. Currency in USD
Add to watchlist
Full screen
Previous CloseN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters20 hours ago

    UPDATE 2-FDA declines to approve J&J arthritis drug sirukumab

    The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday. The FDA's decision is in keeping with an advisory panel's recommendation in August that the FDA reject the drug. "We are disappointed by this development as we feel the data accumulated to date support the efficacy and safety of sirukumab," He added that the company is seeking to "gain a full understanding of FDA requirements for U.S. approval" and plans to have a follow-up discussion with the agency.

  • 3 Top Stocks on Sale This Fall
    Motley Fool23 hours ago

    3 Top Stocks on Sale This Fall

    Long-term investors take note, because bargains abound.

  • 12 Flu Season Facts You Need to Know
    Motley Fool2 days ago

    12 Flu Season Facts You Need to Know

    Here's everything you've ever wanted to know about influenza and flu vaccines.